Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
33.65
+0.68 (2.06%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Oruka Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 1,629 | 679 |
| Enterprise Value | 1,130 | 325 |
| Last Close Price | 33.65 | 19.39 |
| PB Ratio | 3.36 | 1.78 |
| P/TBV Ratio | 3.37 | 1.79 |
| Debt / Equity Ratio | 0.00 | 0.00 |
| Net Debt / Equity Ratio | -1.02 | -1.03 |
| Net Debt / EBITDA Ratio | 3.99 | 4.12 |
| Net Debt / FCF Ratio | 5.55 | 6.20 |
| Quick Ratio | 16.65 | 28.80 |
| Current Ratio | 16.94 | 28.89 |
| Return on Capital Employed (ROCE) | -25.60% | -24.90% |
| Earnings Yield | -5.13% | -13.46% |
| FCF Yield | -5.52% | -9.33% |
Source: S&P Capital IQ. Standard template.
Financial Sources.